Concise answers when you need the essentials, with deeper clinical context and transparent source links when the decision needs more scrutiny.
Search by active ingredient or familiar medicine name.
A three-part injection used during adult cataract surgery. Tropicamide and phenylephrine enlarge the pupil, while lidocaine numbs the inside of the eye.
A local treatment for piles and anal itching. Lidocaine numbs discomfort, while zinc oxide soothes and protects the affected area.
An amide local anaesthetic that temporarily blocks pain signals. Selected products include a throat spray for severe sore-throat pain and an injection used by trained clinicians for local anaesthesia and nerve blocks.
Light liquid paraffin is an emollient that leaves an oily barrier on the skin, reducing water loss and improving hydration. Selected bath and shower preparations cleanse and soothe dry, itchy skin.
This paraffin-based emollient cream softens and moisturises dry skin. It forms a protective surface film that reduces water loss and supports conditions such as eczema, contact dermatitis and ichthyosis.
Linaclotide is a gut-acting guanylate cyclase-C receptor agonist for symptoms of moderate to severe irritable bowel syndrome with constipation in adults, including constipation, abdominal pain and bloating.
Linagliptin is an oral DPP-4 inhibitor for adults with type 2 diabetes. It supports blood glucose control alongside diet and exercise, either alone when metformin is unsuitable or with other diabetes treatments.
This prescription combination contains linagliptin, a DPP-4 inhibitor, and metformin, a biguanide. It is used alongside diet and exercise to improve blood glucose control in adults with type 2 diabetes.
Linezolid is an oxazolidinone antibiotic used for serious infections caused by susceptible Gram-positive bacteria, including some resistant strains. Treatment is normally started in hospital after specialist advice.
Liothyronine sodium is a synthetic form of triiodothyronine (T3), a naturally occurring thyroid hormone. It acts faster and for a shorter time than levothyroxine and is mainly reserved for severe thyroid-hormone deficiency or selected specialist-led situations.
Liquid paraffin is an oily emollient that reduces moisture loss from the skin. In the selected product, it disperses in bath water to soften and protect dry, itchy or scaly skin.
This paraffin-containing aqueous cream relieves dry-skin symptoms and can replace soap during washing. It forms an oily barrier that reduces moisture loss, but its sodium lauryl sulfate may irritate skin, especially in children with atopic eczema.
This oral expectorant mixture was formerly marketed as Mentholated Bronchial Balsam. It was licensed for symptomatic relief of productive coughs and sore throats, but the selected product is discontinued.
Liraglutide is a GLP-1 receptor agonist that reduces appetite, increases fullness and affects glucose-dependent insulin and glucagon release. Selected products are licensed for weight management alongside dietary and physical-activity measures; other products may be licensed for type 2 diabetes.
Lisdexamfetamine dimesylate is a central nervous system stimulant prodrug converted in the blood to dexamfetamine. Selected Elvanse capsules are licensed as part of a comprehensive ADHD treatment programme under specialist supervision.
Lithium carbonate is a mood stabiliser used mainly for mania and bipolar affective illness. Safe use depends on regular blood tests because effective and toxic concentrations can be close.
Lithium citrate is a liquid form of lithium, a mood stabiliser used for mania and hypomania, prevention of recurrent affective illness, and some recurrent depression when antidepressants have not worked.
A live oral vaccine containing a weakened human rotavirus strain. It helps protect infants against gastroenteritis caused by rotavirus but does not prevent diarrhoea or vomiting from other infections.
Lodoxamide trometamol is a prescription-only anti-allergic eye treatment that stabilises mast cells. It is used for non-infectious allergic conjunctivitis, including vernal, giant papillary and allergic-atopic forms.
Lofepramine hydrochloride is a tricyclic antidepressant. The selected oral suspension is licensed to treat symptoms of depressive illness by changing monoamine signalling in the brain.
Lomitapide is a specialist lipid-lowering treatment for adults with homozygous familial hypercholesterolaemia, a rare inherited cause of extremely high cholesterol. It is used alongside a low-fat diet and other lipid-lowering treatments, sometimes including LDL apheresis.
Lomustine is an oral cytotoxic chemotherapy from the nitrosourea group, used with other cancer treatments for certain brain tumours and other cancers.
Loncastuximab tesirine is an antibody–drug conjugate that targets CD19 on B cells and delivers a cell-killing payload. In the UK, it is licensed on its own for adults with relapsed or refractory diffuse large B-cell lymphoma or high-grade B-cell lymphoma after two or more systemic treatments.
Loperamide hydrochloride is an antimotility treatment that reduces diarrhoea by slowing movement through the bowel. It treats symptoms but does not correct dehydration or the underlying cause.
This combines an antimotility treatment for diarrhoea with an antifoaming agent for gas-related discomfort. It is used for sudden diarrhoea with bloating, cramps or flatulence.
Lopinavir + ritonavir is an antiretroviral combination used with other treatments to control HIV-1 infection. Lopinavir suppresses the virus, while ritonavir increases lopinavir exposure. It does not cure HIV.
Loprazolam mesilate is a prescription benzodiazepine hypnotic used for short-term treatment of severe insomnia. It can help when falling asleep is difficult or sleep is repeatedly interrupted.
Loratadine is a less-sedating antihistamine that blocks histamine involved in allergic reactions. It is commonly used to relieve allergic rhinitis symptoms and itchy hives.
Lorazepam is a benzodiazepine that reduces excessive brain activity. Selected products are licensed for severe anxiety, anxiety-related insomnia, procedural premedication and, for the injection, certain acute hospital emergencies including status epilepticus.
Lorlatinib is a targeted anticancer treatment called an ALK tyrosine kinase inhibitor. It is used alone for adults with advanced ALK-positive non-small-cell lung cancer, either before another ALK inhibitor or after the cancer has progressed following one.
Lormetazepam is a benzodiazepine hypnotic that reduces brain activity and promotes sleep. It is licensed for short-term treatment of insomnia that is disabling or causing extreme distress.
Loteprednol etabonate is a corticosteroid applied directly to the eye. The selected UK product is licensed to reduce inflammation following eye surgery.
Lumasiran sodium is a small interfering RNA treatment for primary hyperoxaluria type 1, an inherited condition causing excess oxalate production. It reduces oxalate formation and is used under specialist supervision in people of all ages.
Lurasidone hydrochloride is an atypical antipsychotic. The selected product is licensed to treat schizophrenia in adults and adolescents aged 13 years and over.
Lutetium (177Lu) oxodotreotide is a targeted radioactive treatment for certain neuroendocrine tumours. It carries radiation to tumour cells that have somatostatin receptors, with the aim of controlling progressive disease.
A therapeutic radiopharmaceutical that carries lutetium-177 radiation to prostate cancer cells expressing prostate-specific membrane antigen (PSMA). It is used for selected adults with PSMA-positive metastatic castration-resistant prostate cancer after specified previous treatments or when taxanes are unsuitable.
Lutropin alfa is a recombinant form of human luteinising hormone (LH). It is used with follicle-stimulating hormone (FSH) to support ovarian follicle development in adult women with severe LH and FSH deficiency.
Lymecycline is a tetracycline antibiotic used mainly for acne. Selected UK products are also licensed for certain infections caused by susceptible bacteria.